Announced Thu, 21 Aug · 18:29 IST

Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/08/2025 ,inter alia, to consider and approve 1. To convene the 6th ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Asston Pharmaceuticals Ltd has informed BSE about a Board of Directors meeting scheduled for Monday, 25 August 2025 at 2:30 PM. The main items on the agenda are convening the company's 6th Annual General Meeting and approving the draft AGM notice and explanatory statement. The Board will also consider and approve the Board's Report along with the Management Discussion and Analysis Report for the financial year ended 31 March 2025. Any other incidental matters may also be taken up. The intimation has been filed under SEBI LODR Regulation 29 and signed by Managing Director Ashish Narayan Sakalkar from Mumbai.

Likely market impact

This is a routine compliance filing, but investors should watch for the AGM date, record date/book closure, and the contents of the annual report once approved. No major corporate action is indicated in the agenda.